Swanston Labs
Seed Round in 2025
Swanston Labs builds data-driven solutions aimed at disrupting the convergence of media, entertainment, technology, and commerce. The company focuses on leveraging innovative technologies to address the $7 trillion global leisure spending market. Swanston Labs operates under the Swanston Organization, which also includes Swanston Family Ventures and Swanston Philanthropy, collectively advancing the mission of innovation and inclusion.
Normunity
Series B in 2025
Normunity is a biotechnology company focused on developing a new class of precision immuno-oncology medicines known as immune normalizers. These innovative therapies aim to restore the body's natural immune response against cancer by targeting novel mechanisms that disrupt immune function. Normunity collaborates closely with the lab of Dr. Lieping Chen at Yale School of Medicine, leveraging proprietary discovery platforms to explore complex interactions between cancer and the immune system. The company's emerging pipeline includes drug programs designed to address the exclusion of T-cells from immune-sensitive tumors and other factors that impede normal immune activity in cancer patients. Normunity operates from locations in Boston, Massachusetts, and West Haven, Connecticut.
VeraDermics
Series B in 2024
VeraDermics is a dermatology company focused on developing innovative drug delivery systems to address skin conditions, particularly warts. The company has created a dissolvable microneedle patch that allows for the painless administration of immunotherapy, which harnesses the body's immune response to combat the wart virus. This patch is designed for easy application, functioning like a bandage and remaining on the skin for less than an hour. During this time, microneedles made from immune stimulators dissolve from the patch into the skin, providing a sustained release of treatment over several weeks. By offering a straightforward and effective solution, VeraDermics aims to enhance patient experiences and outcomes in dermatological care.
Nimbus Power Systems
Pre Seed Round in 2024
Nimbus Power Systems is dedicated to creating a cleaner world through the design and integration of zero-emission fuel cell systems specifically targeted at heavy-duty markets. The company specializes in advanced fuel cell technology, offering solutions that provide one-to-one replacements for diesel engines. Nimbus Power Systems enhances cell performance through its innovative architecture, which eliminates the need for a DC/DC converter. This enables clients to utilize hydrogen fuel cells that operate without producing harmful emissions, contributing to a more sustainable future.
Crew Carbon
Seed Round in 2024
CREW Carbon is a company dedicated to removing greenhouse gas emissions, particularly carbon dioxide, from wastewater through innovative technology. Utilizing engineered enhanced weathering, the company's approach harnesses the natural power of minerals to treat both municipal and industrial wastewater while permanently storing CO2. Operating within the environmental services sector, CREW Carbon focuses on greenhouse gas management and carbon removal, aiming to support businesses and governments in achieving their climate objectives. Through its climate tech solutions, the company strives to make a positive environmental impact.
GoodSam is a food and beverages company specializing in the production of snack and food products crafted from natural ingredients. The company operates a chocolate brand that focuses on manufacturing cocoa products sourced from regenerative farming practices. Its product offerings include a variety of items such as coffee, nuts, fruits, and seeds, as well as a range of chocolate products. This includes a sugar-free, vegan, and keto-friendly line that features chocolate bars, chocolate chips, and chocolate-coated nuts. These products incorporate allulose, a natural low-calorie sweetener derived from dates and figs, enabling GoodSam to provide healthier options that support small farmers.
AmpUp is a Silicon Valley-based company that specializes in electric vehicle charging solutions. It develops a reservable networking software that facilitates electric vehicle charging for drivers, hosts, and fleets. The company's platform establishes a peer-to-peer electric vehicle charging network, allowing businesses and property owners to manage multiple charging stations efficiently. By listing their chargers on AmpUp's network, users can earn revenue while contributing to electrification efforts. The software is designed to make the charging experience seamless and stress-free, catering to a diverse range of communities and enabling easy access to charging technology services.
Air Company
Series B in 2024
Air Company is a carbon utilization firm focused on transforming carbon dioxide into consumer and industrial products. Utilizing its patented Carbon Conversion Reactor, the company mimics photosynthesis by combining air, water, and renewable energy to produce carbon-negative alcohols and fuels. Its product line includes AIR Vodka, AIR Hand Sanitizer, and AIR Eau de Parfum, showcasing its commitment to eco-friendly offerings. The company is advancing towards large-scale production of sustainable aviation fuel (SAF), which will be certified for sustainability by recognized organizations. With $40 million in venture capital funding and numerous prestigious awards, including TIME Best Inventions and the Keeling Curve Prize, Air Company aims to redefine the possibilities of carbon technologies and promote a regenerative future that harmonizes with nature.
Oxylus Energy
Seed Round in 2024
Oxylus Energy is a carbon conversion company focused on developing innovative technology for the generation of e-fuels. The company utilizes a proprietary electrochemical process to convert captured carbon dioxide into methanol, a clean-burning and versatile fuel. By transforming waste CO2 into a sustainable energy source, Oxylus Energy aims to provide competitive, scalable solutions that support decarbonization efforts in the industrial sector. This approach not only helps reduce reliance on fossil fuels but also promotes a circular economy by integrating carbon capture and conversion into energy production.
Halda Therapeutics
Series B in 2024
Halda Therapeutics is a research-stage drug discovery company dedicated to developing next-generation precision medicine. The company employs a unique therapeutic modality that serves as a platform for addressing various disease states. By focusing on the discovery of novel therapies that modify disease-causing pathways, Halda Therapeutics aims to enable healthcare providers to offer more targeted treatments for their patients. Through its innovative approach, the company seeks to advance the field of precision medicine and improve patient outcomes.
Aware Recovery Care
Venture Round in 2024
Aware Recovery Care is a healthcare company specializing in in-home addiction treatment services for young adults struggling with drugs and alcohol. Their innovative, evidence-based model transforms the home into a treatment center, offering comprehensive care including withdrawal management, medication-assisted treatment, individual and family therapy, and integrated medical and behavioral health services. This approach enables patients to seek recovery while maximizing whole-person wellness and fostering collaborative care with individuals who have lived experience in addiction recovery.
Encapsulate
Seed Round in 2024
Encapsulate is a biotechnology company focused on developing automated tumor-on-a-chip systems that facilitate personalized cancer treatment. The company's innovative technology allows for the growth of patients' cancer cells outside the body, creating micro tumors that can be preserved and utilized to assess the efficacy of various chemotherapy and biotherapeutic drugs. By screening the response profile of cancer patients to these treatments, Encapsulate aims to enable oncologists to tailor effective treatment regimens, improving outcomes in cancer care.
Quantum Circuits
Venture Round in 2024
Quantum Circuits, Inc. is a New Haven, Connecticut-based company that develops, manufactures, and sells superconducting quantum computers. Founded in 2015 by Dr. Robert Schoelkopf, a leading figure in quantum science, the company focuses on creating full-stack quantum computing solutions that prioritize error correction to enhance scalability. Utilizing a dual-rail qubit design, Quantum Circuits aims to reduce the number of physical qubits needed for logical qubit operations by a factor of ten, thereby streamlining the path to fault-tolerant quantum computing. The company's innovative approach allows for efficient quantum computations, making it a significant player in the advancement of quantum technology and its applications in research and industry.
Manifest Technologies
Seed Round in 2024
Manifest Technologies advances AI-powered computational neuroimaging system that quantifies neural and symptom data.
Conduce Health
Seed Round in 2024
Conduce Health is a healthcare technology company that offers a comprehensive solution for multi-specialty value-based care. It operates a platform designed to connect risk-bearing entities with specialists, addressing the challenges in specialty care management. The company focuses on providing downside protection for specialty care risks while streamlining the contracting process to facilitate participation in value-based care models. Additionally, Conduce Health aims to enhance patient volume and ensure that patients are matched with the most suitable specialists. Through its innovative approach, the company seeks to promote healthier lives by delivering personalized care and encouraging proactive well-being.
DeepLook Medical
Seed Round in 2024
DeepLook Medical is a developer of advanced medical imaging software focused on enhancing the early detection of breast cancer through mammograms. The company's technology employs shape-recognition software to analyze radiological images, particularly those of dense breast tissue, uncovering subtle data that is often difficult for human eyes to discern. By revealing unique radiomic features that reflect tissue morphology, DeepLook Medical's software aids physicians in reducing false positives, thereby minimizing unnecessary surgical procedures. Additionally, the company maintains a phenotype database of breast cancer morphology, which is available for research purposes, contributing to the advancement of breast cancer detection and treatment methodologies.
Nest Collaborative
Series A in 2024
Nest Collaborative is a healthcare company that focuses on providing comprehensive lactation support through its online platform. It connects parents and parents-to-be with board-certified lactation consultants who offer virtual counseling services year-round. The company's approach emphasizes preventive care, aiming to improve access to lactation support and reduce associated costs. By employing evidence-based interventions, Nest Collaborative addresses the unique challenges many families face when breastfeeding, including physiological, emotional, societal, and economic barriers. Its services encompass breastfeeding education, prenatal planning, and practical tips for balancing motherhood, allowing mothers to access consultations without the need for co-pays. Through these offerings, Nest Collaborative seeks to extend the duration of breastfeeding and enhance the overall experience for families.
Vytyl Health Management
Series A in 2024
Vita Health operates an online mental health care platform focused on providing high-quality treatment for adolescents and transitional age youth. The platform enables patients to receive quick and accessible care from licensed therapists through telehealth services. It addresses various mental health challenges, including anxiety, depression, and suicidal ideation, ensuring that young individuals can conveniently access the support they need from the comfort of their homes.
IntelliBoard
Venture Round in 2023
IntelliBoard, Inc. is a technology company based in Monroe, Connecticut, founded in 2015. It specializes in developing a learning analytics platform that serves educational institutions and corporate clients by providing insightful reporting and data analysis. The platform integrates with various Learning Management Systems to deliver real-time data on learner engagement, performance, and the effectiveness of educational content. By transforming raw data into accessible and visually appealing reports, including charts and graphs, IntelliBoard empowers educators and administrators to make informed decisions that enhance learning outcomes and operational efficiency. Its focus on both higher education and corporate training allows IntelliBoard to support clients in achieving their educational goals and optimizing their e-learning investments.
Cambium Carbon
Seed Round in 2023
Cambium Carbon is an early-stage social enterprise focused on addressing climate change through innovative reforestation and urban wood reuse initiatives. The company collaborates with cities and various public and private partners to salvage fallen city trees that would otherwise end up in landfills. By transforming this wood waste into valuable resources, Cambium Carbon establishes reforestation hubs that create a circular economy for urban forests. These hubs not only generate revenue to support tree planting and maintenance projects but also foster sustainable job creation and contribute to the development of resilient urban environments. Through its efforts, Cambium Carbon aims to implement systems-level natural climate solutions that benefit both the environment and local communities.
Summer is a property management company that specializes in facilitating access to vacation homes through a unique rent-to-own program combined with short-term rentals. The company operates a homeownership platform designed to assist clients in purchasing second homes while also offering the opportunity to rent them out. By lowering entry and ongoing costs and minimizing the complexities associated with traditional real estate transactions, Summer enables users to easily find move-in-ready homes or select their ideal second home. Through its services, Summer aims to simplify the process of homeownership and enhance the vacation rental experience for clients.
SLOOH
Venture Round in 2023
Slooh, LLC, founded in 2003 and based in Washington Depot, Connecticut, specializes in providing online access to robotic telescopes located at various observatory sites. The company aims to democratize astronomy by making it engaging and affordable for individuals and educational institutions. Slooh connects telescopes to the internet, allowing users to view celestial objects in real-time and participate in astronomical discoveries. Its automated observatories, notably located on Mt. Teide and in Chile, serve as platforms for broadcasting live celestial events, which are narrated by astronomy experts and shared with global media outlets. Slooh has developed a strong community of members who have taken millions of photos and contributed numerous submissions to the Minor Planet Center. The company also collaborates with NASA, reinforcing its commitment to making space exploration accessible to everyone while providing educational support to schools lacking the necessary resources.
Anonybit
Seed Round in 2023
Anonybit is a technology company that specializes in creating a decentralized framework designed to enhance compliance, protect identities, and secure personal assets. The company has developed a patented infrastructure focused on biometrics, which allows for the encryption of sensitive data, including biometrics and private keys, distributing this information across a peer-to-peer network of nodes. Anonybit's flagship product, the Genie, serves as an integrated identity management platform that prioritizes privacy by design. It facilitates the entire lifecycle of digital identity management, from onboarding to authentication, effectively addressing security vulnerabilities that could be exploited by attackers. By utilizing proprietary multi-party computing and zero-knowledge proofs, Anonybit enables decentralized matching functions, ensuring that users can safeguard their personal identities online.
Modifi Bio
Seed Round in 2023
Modifi Biosciences specializes in direct DNA modification and the development of innovative cancer therapeutics. The company focuses on a unique strategy that involves altering tumor DNA to make cancer cells irreparable, while ensuring that healthy cells remain unharmed. This approach allows researchers to challenge and advance traditional methods of oncology drug development, potentially leading to more effective treatments for a variety of cancers. By exploiting DNA defects found in cancer cells, Modifi Biosciences aims to contribute significantly to the field of cancer research and therapy.
Raise Green
Seed Round in 2023
Raise Green is a financial technology company focused on promoting a sustainable future through accessible investment in clean energy and climate solution projects. The company operates an equity crowdfunding platform that empowers everyday individuals to invest in green infrastructure initiatives. By facilitating community-driven project financing, Raise Green enables local leaders to develop and manage their own clean energy projects, such as community solar initiatives. This approach not only democratizes renewable energy ownership but also enhances community resilience and supports the transition to a decarbonized economy. Through its innovative platform, Raise Green aims to combat climate change and address income inequality, providing essential tools for both project creators and investors to engage directly in sustainable ventures.
Oova Inc. is a New York-based company that specializes in personalized fertility diagnostics. Founded in 2017 and spun out from Mount Sinai Hospital, Oova develops a fertility test kit that utilizes a paper-based strip to measure key hormones present in women’s urine. This innovative device allows users to monitor their fertility profile over time through daily urine samples, leveraging patent-pending biochemistry and artificial intelligence. By accurately tracking hormone levels, Oova aids women in cycle management, assesses menstrual health post-pregnancy, and identifies reproductive health issues such as polycystic ovary syndrome (PCOS). The system is designed for convenience, enabling women to achieve their conception goals without significantly disrupting their daily routines, while providing valuable insights to both patients and healthcare providers through real-time testing and wellness guidance via a mobile application.
Driver Technologies
Venture Round in 2023
Driver Technologies Inc. is a New York-based company that specializes in developing mobile application software aimed at enhancing road safety and improving the driving experience. Founded in 2017, the company offers a hardware-free app that allows users to video record their trips while receiving real-time alerts for potential hazards, such as the risk of colliding with other vehicles or pedestrians, lane drifting, and driver distraction. The app also features voice control capabilities, enabling users to interact with their devices safely while driving. In addition to its primary safety functions, the application provides augmented reality navigation and access to various entertainment and communication options, making it a comprehensive tool for modern drivers. By combining video recording with artificial intelligence-driven alerts, Driver Technologies aims to empower users to document their journeys, enhance their safety, and potentially reduce auto insurance costs.
2045 Studio
Pre Seed Round in 2023
2045 Studio operates as an exclusive professional networking platform, fostering connections among influential individuals of color. It partners with corporations to enhance employee diversity, inclusion, and advancement through its B2B services, which focus on cultivating inclusive leadership. Additionally, 2045 Studio offers a B2C service allowing users to join curated networks based on industry and shared experiences, promoting personal and professional growth.
Inbox Health
Series B in 2023
Inbox Health Corp. is a digital healthcare company based in New Haven, Connecticut, founded in 2014. It specializes in developing a patient communication platform aimed at medical billers in the United States. The Inbox Health platform automates the patient communication process through bi-directional correspondence and utilizes proprietary algorithms, machine learning, and artificial intelligence. This enables patients to better understand their medical bills and access various payment options. By analyzing a wide range of data points across its customer base, the platform allows billers to personalize the billing, payment, and communication experiences for each patient, ultimately enhancing patient collections and overall satisfaction. The company's mission is to reduce administrative waste in healthcare by streamlining the billing and payment experience for patients.
RNAConnect
Seed Round in 2023
RNAConnect specializes in developing enzymatic tools for visualizing and manipulating RNA, with a focus on low-abundance and long, structured RNAs. Their core product is a reverse transcriptase designed to provide greater visibility into these challenging RNA types and their various isoforms. This enzyme is optimized to synthesize cDNA with high fidelity and processivity, enabling researchers to study complex RNA template structures without the need for heat.
Bright Feeds
Seed Round in 2023
Bright Feeds is a food waste recycling company that addresses climate change and global food insecurity by transforming food waste into animal feed. Utilizing artificial intelligence and advanced drying technology, Bright Feeds diverts unwanted food from landfills and converts it into a nutrient-rich alternative to traditional feed sources like soy and corn. This innovative approach not only helps businesses meet their sustainability objectives but also enhances profit margins by turning food waste into high-quality nutritious feed for livestock. Through its services, Bright Feeds contributes to a more sustainable food system while tackling the challenges associated with food waste.
ReferWell
Series B in 2023
ReferWell is a healthcare technology company that offers a cloud-based platform designed to address the challenges associated with care transitions. By connecting healthcare providers into Virtually Integrated Networks, ReferWell enhances the patient journey through better visibility and management of all interactions. The platform facilitates streamlined referrals, point-of-care appointment scheduling, and supports care teams with tools like provider directory management and telehealth capabilities. This comprehensive suite of services enables healthcare providers and networks to improve patient compliance, reduce leakage, and close care gaps, ultimately leading to increased revenue and enhanced patient outcomes.
Bags is a loan discovery and management platform, built by and for the culture.
CINCH Holdings
Pre Seed Round in 2022
CINCH has created the first end-to-end real estate transaction ecosystem, providing agents and brokers everything they need to get deals done within a single application.
Peer Robotics
Seed Round in 2022
Peer Robotics is a collaborative mobile robotics company focused on creating end-to-end material handling solutions tailored for small and medium-scale manufacturers. The company develops human-centric and adaptable mobile robots that facilitate effective collaboration between humans and machines. These robots are designed to learn from human operators in real-time, enhancing efficiency in various tasks such as material movement, packaging, sorting, and visual inspection within warehousing, manufacturing, and assembly environments. By providing innovative solutions for material handling, Peer Robotics aims to improve operational efficiency and ensure timely delivery of goods for its clients.
Aceiss is a developer of a compliance monitoring platform that enhances access security by providing visibility and insights into user access. The company's technology seamlessly integrates with existing applications and security infrastructures, allowing businesses to identify anomalous behavior and monitor privileged accounts. This proactive approach enables organizations to anticipate security threats, ensuring better protection of their sensitive data and resources. Aceiss aims to empower businesses by delivering instant insights that improve their overall security posture.
Modifi Bio
Seed Round in 2022
Modifi Biosciences specializes in direct DNA modification and the development of innovative cancer therapeutics. The company focuses on a unique strategy that involves altering tumor DNA to make cancer cells irreparable, while ensuring that healthy cells remain unharmed. This approach allows researchers to challenge and advance traditional methods of oncology drug development, potentially leading to more effective treatments for a variety of cancers. By exploiting DNA defects found in cancer cells, Modifi Biosciences aims to contribute significantly to the field of cancer research and therapy.
Noteworthy AI
Seed Round in 2022
Noteworthy AI is an infrastructure intelligence company that specializes in enhancing the management and evaluation of energy distribution grids. The company provides fleet vehicle-mounted smart cameras equipped with artificial intelligence, designed to assist utility companies in improving the reliability, resiliency, and safety of electric distribution networks. By autonomously operating during routine vehicle activities, Noteworthy AI's technology enhances situational awareness and facilitates cost savings across various applications, such as geolocation, asset inventory, asset inspection, vegetation management, joint use compliance, and lighting audits. The data captured by these smart cameras is transmitted to an AI-based platform that monitors equipment conditions and alerts users to potential defects, enabling electric utilities to achieve greater operational efficiency and reduce maintenance costs.
FinTron is a fintech company that focuses on providing investing and banking solutions tailored for the mobile generation, particularly targeting young post-college graduates. The company offers a platform that combines essential financial data, allowing users to manage and track their debt, savings, and investment accounts in one place. By providing curated investment portfolios and educational resources, FinTron aims to equip its users with the knowledge and tools necessary to start their investing journey and enhance their financial freedom.
Torigen Pharmaceuticals
Venture Round in 2022
Torigen Pharmaceuticals is a company dedicated to advancing cancer care solutions for companion animals. Founded in 2013 by Ashley Kalinauskas and Mark Suckow, the company is based in Farmington, Connecticut. Torigen focuses on developing innovative immunotherapy treatments, including an experimental autologous cancer vaccine that activates the immune system to target specific tumor-associated antigens on cancer cells. This approach aims to enable veterinarians to detect and treat cancer in animals more effectively, reducing the reliance on invasive surgeries and chemotherapy. By leveraging existing scientific research, Torigen seeks to improve outcomes for pets diagnosed with cancer, enhancing their quality of life through novel therapeutic strategies.
PlazMod Technology
Pre Seed Round in 2022
PlazMod Technology specializes in developing and implementing innovative battery manufacturing processes. The company focuses on a groundbreaking materials processing technology designed to facilitate the production of structured materials systems. This technology aims to support industries worldwide in transitioning their energy systems towards greater electrification, contributing to a more sustainable global energy landscape.
Upswing Health
Seed Round in 2022
Upswing Health is a digital orthopedic clinic that transforms the delivery of orthopedic care by combining artificial intelligence with medical expertise. The company focuses on managing low- and medium-acuity orthopedic conditions, such as injuries to the ankle, knee, elbow, and shoulder, as well as sprains and fractures. Through its community-powered platform, Upswing Health enables athletes to accurately identify injuries and guides them on their recovery journey. The innovative care delivery model not only enhances patient outcomes but also reduces healthcare costs, ensuring that athletes have convenient access to quality information and support from both athletic trainers and orthopedic specialists.
Encapsulate
Convertible Note in 2022
Encapsulate is a biotechnology company focused on developing automated tumor-on-a-chip systems that facilitate personalized cancer treatment. The company's innovative technology allows for the growth of patients' cancer cells outside the body, creating micro tumors that can be preserved and utilized to assess the efficacy of various chemotherapy and biotherapeutic drugs. By screening the response profile of cancer patients to these treatments, Encapsulate aims to enable oncologists to tailor effective treatment regimens, improving outcomes in cancer care.
CoreChain Technologies
Seed Round in 2022
CoreChain Technologies is a business-to-business payments network that leverages blockchain technology to enhance the efficiency of financial transactions between companies. Its digital payment platform facilitates the seamless exchange of transaction data and funds, automating processes that are often manual and prone to errors. By creating a secure environment for these transactions, CoreChain Technologies aims to reduce reconciliation challenges and unlock working capital that may otherwise be tied up. The company's focus is on providing a streamlined solution for B2B payments, enabling businesses to engage in safe and efficient financial exchanges.
Source Defense
Series B in 2022
Source Defense Ltd. is a cybersecurity company specializing in website security software that prevents attacks originating from third-party sources. Founded in 2014 and headquartered in Rosh-ha’ayin, Israel, with additional offices in Beer-Sheva and Stamford, Connecticut, the company offers a cloud-based Software-as-a-Service platform. This platform enables site owners to effectively manage their security by setting and enforcing permissions, receiving real-time alerts, and monitoring the activities of third-party vendors on their sites. Source Defense aims to eliminate the security risks associated with third-party integrations, allowing businesses to save significant time and resources while maintaining high performance and safety for site visitors. Its tailored solutions include VICE products designed for various sectors, including financial institutions, insurance companies, e-commerce, and publishing.
Covr Financial Technologies
Series B in 2022
Covr Financial Technologies, Inc. is a digitally enabled brokerage general agency based in Boise, Idaho, founded in 2013. The company specializes in providing life, long-term care, and disability insurance solutions tailored for financial institutions, advisors, and their clients. Covr offers a suite of digital platforms, including Covr Advisor, which helps financial advisors meet their clients' insurance needs by selecting appropriate products; Covr Consumer, which allows banks and credit unions to sell life insurance directly to customers; and Covr Insights, a tool for managing and analyzing existing life insurance policies. The company serves over 24,000 financial advisors and 13 million customers across 30 financial institutions, facilitating a simplified and efficient sales process for life insurance products.
1906
Venture Round in 2022
1906 is a cannabis company founded in 2016, dedicated to producing fast-acting, functional products designed to enhance wellness. Named after the year when cannabis was last widely recognized as a medicinal option, the company aims to reintegrate the plant into modern health practices rather than limiting its use to recreational purposes. Unlike many cannabis brands that prioritize high THC content, 1906 focuses on health-conscious consumers who seek precise and predictable effects. Its innovative fast-acting technology allows products to take effect within 20 minutes, contrasting with typical edibles that may require up to two hours. By offering a range of products targeting specific wellness needs—such as sleep, focus, relaxation, energy, and intimacy—1906 caters to professionals, busy parents, athletes, and health enthusiasts. The company has established itself as a leader in the functional cannabis market and expanded accessibility through a direct-to-consumer platform launched in 2023. With strong growth driven by demand for wellness-oriented cannabis, 1906 is well-positioned for continued success as legalization and consumption trends evolve across the United States.
Nest Collaborative
Seed Round in 2022
Nest Collaborative is a healthcare company that focuses on providing comprehensive lactation support through its online platform. It connects parents and parents-to-be with board-certified lactation consultants who offer virtual counseling services year-round. The company's approach emphasizes preventive care, aiming to improve access to lactation support and reduce associated costs. By employing evidence-based interventions, Nest Collaborative addresses the unique challenges many families face when breastfeeding, including physiological, emotional, societal, and economic barriers. Its services encompass breastfeeding education, prenatal planning, and practical tips for balancing motherhood, allowing mothers to access consultations without the need for co-pays. Through these offerings, Nest Collaborative seeks to extend the duration of breastfeeding and enhance the overall experience for families.
NourishedRx
Seed Round in 2022
NourishedRx is a healthcare service provider that specializes in delivering personalized food solutions to the most vulnerable members of health plans and healthcare systems, particularly those with diet-sensitive chronic health conditions and at risk of nutrition insecurity. Founded in 2019 in Stamford, Connecticut, the company develops unique meal plans and meal prep kits tailored to individuals' eating habits. In addition to its food offerings, NourishedRx provides education and support to promote lasting behavior change among its clients. By focusing on these tailored solutions, the company aims to enhance member engagement and satisfaction, improve clinical outcomes, and generate meaningful cost savings for healthcare systems.
Wellinks, Inc., established in 2014 and headquartered in New Haven, Connecticut, specializes in wearable health technology for orthotics and prosthetics. The company develops a smart strap for scoliosis braces, tracking wear duration and tightness, and providing real-time data to patients, parents, and doctors. This information enables better-informed treatment decisions, enhances patient motivation, and facilitates remote patient monitoring between clinical visits.
VeraDermics
Series A in 2021
VeraDermics is a dermatology company focused on developing innovative drug delivery systems to address skin conditions, particularly warts. The company has created a dissolvable microneedle patch that allows for the painless administration of immunotherapy, which harnesses the body's immune response to combat the wart virus. This patch is designed for easy application, functioning like a bandage and remaining on the skin for less than an hour. During this time, microneedles made from immune stimulators dissolve from the patch into the skin, providing a sustained release of treatment over several weeks. By offering a straightforward and effective solution, VeraDermics aims to enhance patient experiences and outcomes in dermatological care.
futuresTHRIVE
Seed Round in 2021
FuturesTHRIVE is an innovative company that specializes in developing an AI platform aimed at addressing pediatric mental health issues. The platform leverages artificial intelligence, sentiment analysis, and machine learning to create a comprehensive mental health baseline for children. This technology is designed to assist healthcare providers and families in understanding children's unique mental health characteristics, facilitating the early identification of potential mental health conditions. By providing tools that enable easy and frequent tracking of pediatric mental health, FuturesTHRIVE aims to improve the overall approach to youth mental health care, ultimately enhancing outcomes for children and their families.
Lessonbee
Seed Round in 2021
Lessonbee Inc. is an educational technology company that specializes in providing an online learning platform and digital curriculum focused on health and wellness for students in grades K-12. Founded in 2017 and based in Mount Vernon, New York, Lessonbee offers a cloud-based reflective learning system that includes adaptive lessons and a shared content library. This platform enables teachers to access up-to-date, culturally responsive, and medically accurate health education content, track student assignments, and foster student engagement through regular reflection. Additionally, Lessonbee incorporates its proprietary HealthIQ analytics to evaluate student health goals and school climate, recommending personalized content from its extensive library of self-paced classes and video-based lessons aligned with state and national health education standards. By promoting collaboration among educators, parents, and healthcare providers, Lessonbee aims to enhance student well-being and health literacy.
Owl's Brew
Series A in 2021
Owl's Brew, founded in 2013 by tea sommelier Jennie Ripps and Maria Littlefield, specializes in all-natural tea products crafted in New York City. The company offers two main product lines: Owl's Brew Mixer, which features tea-based craft cocktail mixers, and Owl's Brew Boozy Tea. Their beverages are made from whole tea leaves, fruits, spices, and herbs, ensuring that no added or artificial flavors are included. This commitment to quality allows consumers to enjoy a diverse range of flavored tea products that emphasize freshness and natural ingredients.
DiA Imaging Analysis
Venture Round in 2021
DiA Imaging Analysis Ltd. is a technology company based in Beersheba, Israel, specializing in AI-powered ultrasound analysis designed to enhance the evaluation of cardiac function and other medical conditions. Founded in 2009, DiA offers a range of innovative applications, including LVivo EF for automated ejection fraction evaluation, LVivo RV for right ventricle analysis, and LVivo Strain, which assesses myocardial strain as an early indicator of reduced left ventricular function. Their tools simplify the ultrasound imaging process by providing automated analysis and optimal view selection, improving the diagnostic capabilities of clinicians. DiA's technology is compatible with various ultrasound devices and healthcare IT systems, streamlining the detection of clinical abnormalities. The company holds FDA and CE clearances and serves thousands of users globally, addressing critical challenges in ultrasound utilization by enabling more accurate and efficient image analysis through advanced pattern recognition and machine learning algorithms.
Shelf is a knowledge management platform aimed at improving the efficiency of distributed teams by streamlining the process of finding and managing organizational knowledge. The platform addresses the challenges of content disorganization prevalent in remote work environments, where teams may face difficulties in accessing critical information. By leveraging natural language processing, Shelf enhances search capabilities, enabling users to quickly locate the answers they need. The platform integrates knowledge management best practices developed in collaboration with experts, ensuring that users can manage content effectively while reducing the time spent on knowledge retrieval and maintenance. Shelf's mission is to empower teams globally to learn, share, and succeed without the burdens of excessive work or inefficient tools, ultimately reimagining the library concept for the modern workplace.
CoreChain Technologies
Pre Seed Round in 2021
CoreChain Technologies is a business-to-business payments network that leverages blockchain technology to enhance the efficiency of financial transactions between companies. Its digital payment platform facilitates the seamless exchange of transaction data and funds, automating processes that are often manual and prone to errors. By creating a secure environment for these transactions, CoreChain Technologies aims to reduce reconciliation challenges and unlock working capital that may otherwise be tied up. The company's focus is on providing a streamlined solution for B2B payments, enabling businesses to engage in safe and efficient financial exchanges.
BEKHealth
Seed Round in 2021
BEKhealth is a clinical research software company that utilizes an AI-powered platform to enhance the efficiency of clinical trials and observational studies. By automating various processes, BEKhealth enables organizations to better understand their patient populations, optimize feasibility, and speed up site selection. The platform extracts and processes both structured and unstructured data from electronic medical records, allowing for a more comprehensive understanding of trial eligibility criteria. This capability leads to the identification of significantly more protocol-eligible candidates, resulting in a tenfold increase in qualified patients and halving the enrollment timeline. Through its innovative approach, BEKhealth aims to reduce costs and streamline the overall clinical research process for its clients.
Triax Technologies
Series A in 2021
Triax Technologies specializes in a connected Internet of Things (IoT) worksite platform tailored for construction, energy, and heavy industrial sectors. The company aims to enhance safety and efficiency in complex work environments by utilizing innovative technology and real-time data analytics. Its key offering, the Spot-r system, improves worksite visibility and risk management by linking workers, equipment, and operations through a scalable infrastructure that includes wearable devices, sensors, and a cloud-based dashboard. This system provides real-time insights into site access, personnel and equipment locations, safety incidents, and emergency protocols, enabling firms to streamline operations and enhance safety measures. In response to the COVID-19 pandemic, Triax launched Proximity Trace, which offers alerts for social distancing and contact tracing to help protect essential workers and facilitate a safe return to work. Overall, Triax Technologies is committed to transforming challenging work environments through intelligent, data-driven solutions.
Lumeda Inc. is a biotechnology company based in Rocky Hill, Connecticut, founded in 2020. It specializes in developing advanced photonic tools that facilitate intraoperative photodynamic therapy (PDT) for lung cancer treatment. Lumeda's innovative solutions include light delivery instrumentation and proprietary software designed to automate the PDT light delivery process, targeting tumor sites with precision and enhancing treatment efficacy. The company's technology aims to improve the planning and delivery of PDT, offering a more streamlined and effective approach during non-small cell lung cancer surgeries. By integrating advanced photonics and AI-driven software, Lumeda enhances the consistency and reliability of PDT, ultimately aiming to reduce post-operative recurrence and improve patient outcomes. The company collaborates closely with leading medical institutions to advance its solutions in clinical settings.
Inbox Health
Series A in 2021
Inbox Health Corp. is a digital healthcare company based in New Haven, Connecticut, founded in 2014. It specializes in developing a patient communication platform aimed at medical billers in the United States. The Inbox Health platform automates the patient communication process through bi-directional correspondence and utilizes proprietary algorithms, machine learning, and artificial intelligence. This enables patients to better understand their medical bills and access various payment options. By analyzing a wide range of data points across its customer base, the platform allows billers to personalize the billing, payment, and communication experiences for each patient, ultimately enhancing patient collections and overall satisfaction. The company's mission is to reduce administrative waste in healthcare by streamlining the billing and payment experience for patients.
Enko Chem
Venture Round in 2021
Enko Chem, Inc., established in 2017 and based in Woburn, Massachusetts, specializes in the discovery and development of small-molecule and novel products designed to protect crops from pests and diseases. The company's proprietary technology platform enables it to swiftly identify safe and cost-effective solutions, contributing to sustainable food production.
Artizan Biosciences
Series A in 2021
Artizan Biosciences, Inc. is a biotechnology company focused on developing small molecule drugs for human use, particularly targeting diseases linked to intestinal inflammation. Founded in 2016 and headquartered in New Haven, Connecticut, the company employs its proprietary IgA-SEQ technology platform to identify and characterize disease-driving bacteria within the intestinal microbiota. This innovative approach aims to create precision therapeutics that address the root causes of various serious conditions, including digestive disorders, obesity, autoimmune diseases, and a range of other health issues affecting the skin, lungs, and central nervous system. By focusing on unmet medical needs, Artizan Biosciences seeks to provide novel treatment options for patients.
Leal Health
Series A in 2021
Leal Health, formerly known as Trialjectory, is an AI-powered platform focused on improving cancer care by facilitating access to clinical trials. The company connects cancer patients with suitable clinical trials through a comprehensive, patient-first approach that utilizes self-reported clinical information to enhance trial matching and enrollment processes. By working collaboratively with patients, healthcare providers, and pharmaceutical companies, Leal Health aims to democratize advanced cancer treatment options and support patient-centric clinical research. The platform has garnered recognition, being named one of TIME's "100 Best Inventions of 2020" and receiving an honor in the AI and data category at Fast Company's "2021 World-Changing Ideas Awards."
Athena Therapeutics
Seed Round in 2020
Athena Therapeutics, LLC is a biopharmaceutical company based in New Haven, Connecticut, that specializes in developing innovative drugs targeting defects in NAD metabolism related to cancer. Incorporated in 2018, the company employs advanced methodologies to identify and characterize altered states of NAD metabolism, enabling selective targeting of tumor cells while sparing normal tissues. To enhance its research capabilities, Athena has assembled a team of experts in NAD metabolism, including Dr. Emmanuel Burgos, who leads the internal discovery biology efforts. Additionally, the company has established a Scientific Advisory Board comprising prominent figures in the field, such as Professor Vern Schramm and Dr. Leonard Post, who bring extensive knowledge in enzymology and oncology drug development, respectively. This strategic focus positions Athena Therapeutics to advance its drug development pipeline effectively.
Diameter Health
Series B in 2020
Diameter Health, Inc. is a technology company that specializes in developing software solutions for healthcare organizations. Founded in 2013 and headquartered in Farmington, Connecticut, with an additional office in Wellesley, Massachusetts, the company focuses on enhancing the quality and interoperability of patient information. Its flagship product, Fusion, facilitates intelligent data exchange by normalizing and cleansing data from certified Electronic Health Records (EHRs), making it suitable for clinical use and analytics. Diameter Health also offers various other solutions, including Data Dashboard, which provides data quality ratings and dashboards for clinical documentation, and a Payer Edition for generating standardized supplemental reporting data. Additionally, the company provides tools for automatic data updates and scalable hosting solutions. Diameter Health serves a diverse clientele that includes government entities, health information exchanges, payers, healthcare IT vendors, life insurers, and health systems.
Alphina Therapeutics
Venture Round in 2020
Alphina Therapeutics is a biotechnology company focused on developing innovative therapies for cancer patients by targeting specific metabolic deficiencies. The company specializes in the synthetic lethal context of cancer subsets with NAD Metabolic Deficiencies (NMD). By leveraging proprietary biomarkers, Alphina Therapeutics aims to create companion diagnostics and best-in-class targeted therapies that address the NAD pathway nodes in tumors displaying characteristics of NMD. Their approach includes developing new classes of small molecules that selectively target altered states of NAD metabolism, enabling the identification and characterization of these metabolic defects in cancer. This targeted strategy allows for the development of drugs and therapies that prioritize tumor cells while sparing normal tissue, ultimately facilitating the rapid translation of their findings into clinical applications.
WRM Software
Seed Round in 2020
WRM Software specializes in developing business productivity applications aimed at enhancing operational efficiency. Their key offerings include Storm Manager and Ops Manager, which are designed for ease of use and facilitate seamless integration between field and office operations. These applications ensure that all team members have access to the most current information at all times. WRM Software supports emergency response operations and field service management, providing businesses with essential tools to manage their resources effectively.
Azitra Inc. is a clinical-stage biopharmaceutical company based in Farmington, Connecticut, specializing in microbiome-based therapeutics for skin diseases. Founded in 2014, Azitra leverages extensive scientific research on the skin microbiome to develop innovative treatments for various adverse skin conditions. The company’s proprietary platform includes a microbial library of engineered bacterial strains, notably Staphylococcus epidermidis, which are screened for therapeutic properties. In collaboration with researchers from Yale University and the Jackson Laboratory, Azitra employs advanced technologies such as artificial intelligence and machine learning to analyze and predict the efficacy of its strains. The company focuses on precision dermatology by developing live biotherapeutic products and engineered proteins for topical application, aiming to address unmet medical needs in the dermatological field.
Point Pickup
Series A in 2020
Point Pickup Technologies is a mobile app delivery platform that addresses on-demand, pre-scheduled, and recurring same-day delivery needs across various sectors. It offers a comprehensive solution for middle and last-mile deliveries, catering to a wide range of industries including big-box retail, grocery, liquor, and pharmaceuticals. The platform utilizes precise matching technology to connect delivery requests with suitable drivers, which can include everyday individuals with personal vehicles as well as professional commercial drivers. This enables businesses to efficiently deliver goods to their final destinations while providing real-time tracking of packages. Operating across all major markets in the United States, Point Pickup also prioritizes underserved secondary markets, enhancing accessibility for various businesses and consumers.
Biorez, Inc. is a medical device company focused on developing bioresorbable scaffold implants aimed at enhancing tissue regeneration in vivo. Founded in 2008 and based in New Haven, Connecticut, the company offers innovative products such as the L-C Ligament, designed for anterior cruciate ligament (ACL) reconstruction, which eliminates the need for donor tissue harvesting and serves as a superior alternative to cadaver-based materials. Biorez utilizes patented technology involving a degradable polymer, PLLA, in its orthopedic implants to promote the regeneration and augmentation of soft tissue. Among its offerings is the biorez GRAFT, a FDA-cleared device for soft tissue augmentation of the rotator cuff. The company’s bioinductive implants stabilize surgical repairs while the body rebuilds its musculoskeletal tissue, thereby facilitating quicker and safer recovery for patients and providing surgeons with effective tools to improve soft tissue repair outcomes.
IvyTech Design
Seed Round in 2020
IvyTech Design was founded with a mission to develop adjustable-angle orthopedic instruments that can distract, align, and compress bones more precisely than current tools. Our patented and patent-pending technology addresses key challenges in foot and spine procedures, which suffer from high complication rates (up to 20-25%), costly revision surgeries, and suboptimal patient outcomes. IvyTech Design’s instruments will enable surgeons to precisely angle bones, providing superior alignment and access in foot and spine operations. Surgeons, hospitals, and patients will all benefit from this technology, as we aim to lower complication and revision rates, reduce surgical times, and improve patient outcomes.
Shelf is a knowledge management platform aimed at improving the efficiency of distributed teams by streamlining the process of finding and managing organizational knowledge. The platform addresses the challenges of content disorganization prevalent in remote work environments, where teams may face difficulties in accessing critical information. By leveraging natural language processing, Shelf enhances search capabilities, enabling users to quickly locate the answers they need. The platform integrates knowledge management best practices developed in collaboration with experts, ensuring that users can manage content effectively while reducing the time spent on knowledge retrieval and maintenance. Shelf's mission is to empower teams globally to learn, share, and succeed without the burdens of excessive work or inefficient tools, ultimately reimagining the library concept for the modern workplace.
Encapsulate
Pre Seed Round in 2020
Encapsulate is a biotechnology company focused on developing automated tumor-on-a-chip systems that facilitate personalized cancer treatment. The company's innovative technology allows for the growth of patients' cancer cells outside the body, creating micro tumors that can be preserved and utilized to assess the efficacy of various chemotherapy and biotherapeutic drugs. By screening the response profile of cancer patients to these treatments, Encapsulate aims to enable oncologists to tailor effective treatment regimens, improving outcomes in cancer care.
EyeControl
Series A in 2020
EyeControl is a medical technology company that develops innovative communication solutions for individuals with severe speech impairments, such as those affected by locked-in syndrome or ALS. Their flagship product is an intuitive glass frame equipped with an infrared camera, which translates eye movements into spoken commands via a connected computer and earphones/speaker. This device aims to enhance patients' quality of life by facilitating easier communication and improving access to healthcare services.
Voiceitt Ltd., established in 2012 and headquartered in Ramat Gan, Israel, specializes in developing mobile applications that empower individuals with speech impairments or non-standard speech patterns to communicate effectively. The company's core product is an automatic speech recognition platform that translates distorted pronunciation into intelligible speech, providing independence and improved quality of life for users with speech and motor disabilities, as well as serving as a useful tool for their caregivers.
GeneDx Holding
Series C in 2020
GeneDx is a company dedicated to providing personalized and actionable health insights that enhance diagnosis and treatment, ultimately improving health outcomes. Positioned at the intersection of diagnostics and data science, GeneDx combines decades of genomic expertise with the capability to interpret clinical data at scale. The company focuses on accelerating the application of genomic information and large-scale clinical data to establish precision medicine as a standard practice in healthcare. GeneDx leads the transformation of healthcare through its comprehensive exome and genome testing services, leveraging one of the largest rare disease data sets in the world. The business operates through two segments: GeneDx, which generates the majority of its revenue, and Legacy Sema4 diagnostics.
Enrich Therapeutics
Seed Round in 2020
Enrich Therapeutics Inc. is a biotechnology company based in Worcester, Massachusetts, that specializes in developing innovative single-cell isolation technology for life science research. The company offers LASUM, a technology that enables the selection and isolation of single cells using a microscope, applicable to a variety of cell types including suspension, adherent, and challenging tissue samples. Enrich Therapeutics' solutions enhance scalability and affordability across several applications such as antibody drug discovery, next-generation sequencing (NGS), and the development of adoptive cell therapies. In addition to its core technology, the company provides services in phage display library engineering, affinity-on-demand binder selection, CAR-T cell line development, B-cell isolation, and precision cell isolation for NGS analysis. Founded in 2018, Enrich Therapeutics aims to advance life science research through its cutting-edge tools and methodologies.
Simcha Therapeutics
Series A in 2020
Simcha Therapeutics is a biopharmaceutical company focused on developing engineered cytokine immunotherapy for cancer treatment. Founded in 2018 and headquartered in New Haven, Connecticut, the company utilizes directed evolution to create novel cytokines that enhance the immune system's ability to combat diseases. Its lead program, ST-067, is a designer IL-18 cytokine that has demonstrated significant antitumor effects in animal models, both as a standalone treatment and in combination with anti-PD-1 checkpoint inhibitors. This innovative approach aims to provide patients with more effective immunotherapies, thereby improving their ability to fight cancer.
Invixium Inc., founded in 2012 and based in Markham, Canada, is a global provider of biometric solutions designed to enhance safety, health, security, and productivity for enterprises. The company offers a range of products including Ixm Mycro for personalized home environments, Ixm Touch for employee time tracking, IXM Titan for face recognition and edge computing, IXM Merge for indoor fingerprint tracking, and Ixm Sense for industrial installations. Invixium's solutions also include touchless biometric technologies with face recognition and temperature detection for access control, workforce management, and visitor screening. The company's products are deployed across various industries such as government, banking, healthcare, and education in over 60 countries.
1touch.io
Series A in 2020
1touch.io is a developer of an AI-based platform focused on sustainable data discovery and management for privacy, security, and data governance. The company offers a network-based solution that continuously analyzes traffic and repository stores connected to a network, enabling the detection of elements storing, processing, and sharing personal data, both internally and externally. Utilizing artificial intelligence and natural language processing technology, 1touch.io's platform provides automated, near real-time discovery, mapping, and cataloging of sensitive data across various repositories. This capability allows businesses to identify and manage all sensitive data usage effectively, regardless of whether the data is structured, unstructured, in motion, or at rest, including data that may be unknown to them.
Covr Financial Technologies
Convertible Note in 2020
Covr Financial Technologies, Inc. is a digitally enabled brokerage general agency based in Boise, Idaho, founded in 2013. The company specializes in providing life, long-term care, and disability insurance solutions tailored for financial institutions, advisors, and their clients. Covr offers a suite of digital platforms, including Covr Advisor, which helps financial advisors meet their clients' insurance needs by selecting appropriate products; Covr Consumer, which allows banks and credit unions to sell life insurance directly to customers; and Covr Insights, a tool for managing and analyzing existing life insurance policies. The company serves over 24,000 financial advisors and 13 million customers across 30 financial institutions, facilitating a simplified and efficient sales process for life insurance products.
IntelliBoard
Series A in 2020
IntelliBoard, Inc. is a technology company based in Monroe, Connecticut, founded in 2015. It specializes in developing a learning analytics platform that serves educational institutions and corporate clients by providing insightful reporting and data analysis. The platform integrates with various Learning Management Systems to deliver real-time data on learner engagement, performance, and the effectiveness of educational content. By transforming raw data into accessible and visually appealing reports, including charts and graphs, IntelliBoard empowers educators and administrators to make informed decisions that enhance learning outcomes and operational efficiency. Its focus on both higher education and corporate training allows IntelliBoard to support clients in achieving their educational goals and optimizing their e-learning investments.
CytoVeris
Venture Round in 2020
CytoVeris is a company that specializes in the development of optical-based technologies aimed at assisting surgical oncologists in the identification and removal of tumor tissue during cancer resection surgeries. Founded in 2018 by Alan Kersey in Farmington, Connecticut, the company focuses on enhancing surgeons' ability to achieve clean margins, which is critical for successful cancer treatment. CytoVeris's innovative devices provide real-time assessments of tissue and generate molecular-specific information, producing an optical biomolecular fingerprint for cancer detection. This advanced technology allows for the detection of molecular signatures created by cancer cells, which can lead to improved patient outcomes and reduced healthcare costs by minimizing the need for repeat surgeries.
Mindnest Health
Seed Round in 2020
MindNest Health, Inc. is a New Haven, Connecticut-based company that develops a digital platform designed to provide parents with access to clinically validated behavioral interventions for their children. Founded in 2016, MindNest Health focuses on addressing various developmental challenges, offering programs specifically for ADHD, autism, and disruptive behaviors, as well as training modules aimed at anxiety and substance abuse. The platform aims to support parents during critical times when they seek assistance for their children's mental health, thereby reducing barriers to care and alleviating parental stress. By providing evidence-based solutions, MindNest Health envisions fostering an environment where children can reach their full potential and families can thrive.
WAVE Drowning Prevention Systems
Pre Seed Round in 2020
WAVE was created with a mission to end drowning, a leading cause of death in children and adults. Our product works with lifeguards and parents to detect drowning at the first sign of danger.
ReferWell
Venture Round in 2020
ReferWell is a healthcare technology company that offers a cloud-based platform designed to address the challenges associated with care transitions. By connecting healthcare providers into Virtually Integrated Networks, ReferWell enhances the patient journey through better visibility and management of all interactions. The platform facilitates streamlined referrals, point-of-care appointment scheduling, and supports care teams with tools like provider directory management and telehealth capabilities. This comprehensive suite of services enables healthcare providers and networks to improve patient compliance, reduce leakage, and close care gaps, ultimately leading to increased revenue and enhanced patient outcomes.
ProteoWise
Venture Round in 2020
ProteoWise Inc. is a biotechnology company based in Branford, Connecticut, established in 2018. It specializes in the development of 3-dimensional nanoscale protein capturing materials and proteomics instruments that enhance the efficiency and ease of protein analysis. The company’s innovative technology simplifies traditional western blot techniques, offering high information content, high throughput, and cost-effective solutions for researchers. Founded by a team of experienced scientists from the Strittmatter Lab at Yale University, ProteoWise aims to facilitate advancements in proteomics by providing tools that enable high-throughput bench-top applications, thereby supporting the ongoing genomic revolution.
Inbox Health
Venture Round in 2020
Inbox Health Corp. is a digital healthcare company based in New Haven, Connecticut, founded in 2014. It specializes in developing a patient communication platform aimed at medical billers in the United States. The Inbox Health platform automates the patient communication process through bi-directional correspondence and utilizes proprietary algorithms, machine learning, and artificial intelligence. This enables patients to better understand their medical bills and access various payment options. By analyzing a wide range of data points across its customer base, the platform allows billers to personalize the billing, payment, and communication experiences for each patient, ultimately enhancing patient collections and overall satisfaction. The company's mission is to reduce administrative waste in healthcare by streamlining the billing and payment experience for patients.
Aero Therapeutics
Pre Seed Round in 2020
Aero Therapeutics is a medical device company focused on improving the treatment of respiratory issues, particularly in low-resource settings. The company has developed an innovative device specifically designed to address neonatal respiratory problems. This device oxygenates, warms, humidifies, and sterilizes air before delivery, all within a mobile enclosure. By providing affordable and effective solutions, Aero Therapeutics aims to empower clinicians to better care for infants facing respiratory challenges in underserved environments.
Lessonbee
Pre Seed Round in 2020
Lessonbee Inc. is an educational technology company that specializes in providing an online learning platform and digital curriculum focused on health and wellness for students in grades K-12. Founded in 2017 and based in Mount Vernon, New York, Lessonbee offers a cloud-based reflective learning system that includes adaptive lessons and a shared content library. This platform enables teachers to access up-to-date, culturally responsive, and medically accurate health education content, track student assignments, and foster student engagement through regular reflection. Additionally, Lessonbee incorporates its proprietary HealthIQ analytics to evaluate student health goals and school climate, recommending personalized content from its extensive library of self-paced classes and video-based lessons aligned with state and national health education standards. By promoting collaboration among educators, parents, and healthcare providers, Lessonbee aims to enhance student well-being and health literacy.
P2 Science
Series C in 2020
P2 Science, Inc. is a bio-renewable chemistry company based in Woodbridge, Connecticut, that specializes in developing and producing specialty chemicals derived from renewable feedstocks, such as vegetable oils. Founded in 2009 by a team including Yale scientists, P2 Science has created innovative process technologies that transform these sustainable materials into high-value products, including ingredients for flavors, fragrances, and cosmetics, which are traditionally sourced from petrochemicals. The company's offerings cater to various industries, including household and industrial cleaning, personal care, agriculture, environmental remediation, and more. P2 Science aims to support businesses in decarbonizing the chemical industry by providing renewable alternatives to conventional petrochemical ingredients. With a laboratory in New Haven, the company collaborates with major partners across the supply chain to further enhance its technology and market reach.
Enviro Power
Series A in 2020
Enviro Power, LLC is a Connecticut-based company that specializes in developing and marketing innovative heating equipment for both residential and commercial applications. Founded in 2013, the company features its flagship SmartWatt Boiler technology platform, which is designed to generate electricity at near-zero costs while meeting heating demands. This advanced system transforms conventional heating infrastructure into a dual-purpose energy platform, enabling building owners to benefit from reduced utility bills and enhanced grid resiliency. By providing backup power and supporting grid stability, Enviro Power aims to lower carbon footprints and improve energy efficiency for millions of users.
IsoPlexis
Series C in 2020
IsoPlexis is a life science technology company based in Branford, Connecticut, established in 2013. It specializes in developing a single-cell detection system that identifies a wide array of patient immune responses at the single-cell level. The company's platform focuses on cell-based proteomic systems and biomarkers, allowing for the assessment of therapeutic safety and efficacy, monitoring of disease progression, and exploration of functional protein biology and cellular signaling networks. IsoPlexis's technology enables clients to predict cancer patient responses to various novel immunotherapies and cellular therapies, thereby enhancing therapeutic development and informing clinical decision-making.
Better Rhodes
Seed Round in 2020
Better Rhodes is a premium beverage platform specializing in 'Lo and No' alcoholic alternatives, providing a diverse range of alcohol-free spirits, beers, wines, mixers, soft drinks, and adult beverages. The company focuses on delivering high-quality, non-alcoholic options directly to consumers through a subscription model. With an emphasis on product development and go-to-market services, Better Rhodes curates a selection of beverages designed to meet the growing demand for premium, alcohol-free options, catering to health-conscious consumers seeking flavorful alternatives.
BioWave
Venture Round in 2020
BioWave Corporation is a manufacturer of innovative pain management devices that utilize patented technology to block pain signals at their source. The company's product line includes BioWavePENS, a percutaneous electrical nerve stimulation device for severe chronic, acute, and postoperative pain; BioWavePRO, a comprehensive pain therapy system for various pain types; BioWaveHOME, designed for at-home pain relief; and BioWaveGO, an over-the-counter solution for pain management. These devices deliver therapeutic electrical signals through the skin to the underlying tissues, effectively interrupting the transmission of pain signals to the brain, similar to the effect of a chemical anesthetic. BioWave's offerings also consist of accessories and disposable electrodes, serving a diverse clientele that includes professional athletes, U.S. veterans, active military personnel, and pain management specialists. Founded in 1997 and headquartered in Norwalk, Connecticut, BioWave is committed to providing effective neuromodulation therapy for patients seeking relief from various pain conditions.
Pineapple Tech Pty Ltd is a South African company that operates a peer-to-peer insurance platform, providing short-term insurance coverage to its members. Founded in 2017 and based in Johannesburg, the company allows users to pay and track their premiums online while selecting their preferred network for pooling. Pineapple aims to innovate the insurance experience by aligning incentives with users, offering transparency about premium usage, and returning any unused premiums to members. The platform simplifies the insurance process, enabling users to obtain coverage quickly, often in under 60 seconds, by utilizing AI technology. Pineapple launched its "My Stuff" per-item insurance in 2018 and expanded its offerings to include "My Ride" for auto insurance. The company has also formed a partnership with Travelers in the United States and provides a white-labeled version of its platform for that market.
TryCycle Data Systems
Pre Seed Round in 2019
TryCycle Data Systems Inc. is a Canadian company founded in 2016 that specializes in developing technology to assist healthcare professionals in monitoring the symptoms and behavioral patterns of individuals undergoing treatment for substance use, addiction, mental health conditions, and post-traumatic stress disorders. Its innovative predictive health technology provides an early warning system that enables practitioners to detect and address unhealthy and risky behaviors in their patients. By leveraging regular self-assessments submitted to treatment clinics, TryCycle's system helps identify triggers for relapse and allows healthcare providers to focus on patients at the highest risk, ultimately aiming to improve recovery outcomes. The company's approach addresses gaps in care that have historically existed due to fragmented support systems within the treatment landscape.
Azitra Inc. is a clinical-stage biopharmaceutical company based in Farmington, Connecticut, specializing in microbiome-based therapeutics for skin diseases. Founded in 2014, Azitra leverages extensive scientific research on the skin microbiome to develop innovative treatments for various adverse skin conditions. The company’s proprietary platform includes a microbial library of engineered bacterial strains, notably Staphylococcus epidermidis, which are screened for therapeutic properties. In collaboration with researchers from Yale University and the Jackson Laboratory, Azitra employs advanced technologies such as artificial intelligence and machine learning to analyze and predict the efficacy of its strains. The company focuses on precision dermatology by developing live biotherapeutic products and engineered proteins for topical application, aiming to address unmet medical needs in the dermatological field.
Paygilant
Private Equity Round in 2019
Paygilant Ltd. is a technology company founded in 2014 and based in Ramat Gan, Israel, specializing in mobile fraud prevention solutions for online transactions, payments, and money transfers. The company addresses the growing challenge of mobile payment fraud by providing comprehensive solutions that include account takeover prevention, new account fraud detection, and transactional fraud protection. Paygilant's platform is designed to enhance security while ensuring a smooth user experience, employing patented technology and six proprietary intelligence sets to facilitate frictionless authentication. By protecting the entire user journey—from app download to ongoing transactions—Paygilant enables financial institutions and eCommerce providers to safeguard their services against fraudulent activities while maintaining user privacy and trust in the digital banking ecosystem.